Expert views
Surgical prophylaxis with pdVWF/FVIII concentrate in a ratio of 2.4:1 for VWD
Speakers: Günter Auerswald and Will Thomas
In the third video of this capsule video collection based on the findings of their recently published systematic literature review, Günter Auerswald and Will Thomas present the reported outcomes of studies investigating the safety and efficacy of plasma-derived von Willebrand Factor and Factor VIII concentrate (pdVWF/FVIII) in a ratio of 2.4:1 for surgical prophylaxis in von Willebrand disease (VWD).